Incontinence-associated Dermatitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2026-01-12
Clinical Trial Update: COPPER: A Trial Evaluating Copper-based Products for Incontinence-associated Dermatitis [Phase 2, Phase 3]
The COPPER trial evaluating copper-based products for Incontinence-associated Dermatitis has been withdrawn from Phase 2/3.